Skip to main content
. 2019 May 28;11(2):110–117. doi: 10.4274/jcrpe.galenos.2018.2018.0074

Figure 1.

Figure 1

Pathogenesis of low bone mineral density in thalassemic patients

GH-IGF-1: growth hormone-insulin-like growth factor-1